Results 21 to 30 of about 19,009 (196)

Thrombocytopenia between decitabine monotherapy vs decitabine combination.

open access: yes, 2022
Thrombocytopenia between decitabine monotherapy vs decitabine combination.
Romina Brignardello-Petersen (814592)   +7 more
core   +1 more source

Febrile neutropenia events between decitabine monotherapy vs decitabine combination.

open access: yes, 2022
Febrile neutropenia events between decitabine monotherapy vs decitabine combination.
Romina Brignardello-Petersen (814592)   +7 more
core   +1 more source

Decitabine Promotes Modulation in Phenotype and Function of Monocytes and Macrophages That Drive Immune Response Regulation

open access: yesCells, 2021
Decitabine is an approved hypomethylating agent used for treating hematological malignancies. Although decitabine targets altered cells, epidrugs can trigger immunomodulatory effects, reinforcing the hypothesis of immunoregulation in treated patients. We
Fabiana Albani Zambuzi   +5 more
doaj   +1 more source

Pneumonia events between decitabine monotherapy vs decitabine combination.

open access: yes, 2022
Pneumonia events between decitabine monotherapy vs decitabine combination.
Romina Brignardello-Petersen (814592)   +7 more
core   +1 more source

Anemia events between decitabine monotherapy vs decitabine combination.

open access: yes, 2022
Anemia events between decitabine monotherapy vs decitabine combination.
Romina Brignardello-Petersen (814592)   +7 more
core   +1 more source

Efficacy and safety of an HDACi- and HMA-based protocol in adults with acute myeloid leukemia of intermediate- and adverse-risk categories: a retrospective study

open access: yesHematology, 2023
Objective Anthracyclines and cytarabine have comprised standard induction therapy for acute myeloid leukemia (AML) for decades. Low overall survival of AML is due to non-remission or relapse after remission.
Zhibo Guo   +12 more
doaj   +1 more source

Neutropenia events between decitabine monotherapy vs decitabine combination.

open access: yes, 2022
Neutropenia events between decitabine monotherapy vs decitabine combination.
Romina Brignardello-Petersen (814592)   +7 more
core   +1 more source

Synchronous AML and pancreatic neuroendocrine neoplasm, both successfully treated with somatostatin analogs and decitabine

open access: yesEndocrine Oncology, 2023
Downregulation of tumor suppression genes by DNA hypermethylation has been proposed as a potential cause of neuroendocrine neoplasm (NEN) formation. In this report, we present a patient simultaneously diagnosed with acute myeloid leukemia (AML) and a ...
Syed Ehsanullah, Nikolaos A Trikalinos
doaj   +1 more source

Therapeutic effect of folic acid combined with decitabine on diabetic mice [PDF]

open access: yesInternational Journal of Ophthalmology, 2023
AIM: To evaluate the therapeutic effect of folic acid combined with decitabine on diabetic mice. METHODS: The diabetic model of db/db mice were randomly divided into model group, folic acid group, decitabine group, folic acid combined with decitabine ...
Gang Du   +5 more
doaj   +1 more source

Decitabine mildly attenuates MLL‐rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo‐sensitizer

open access: yeseJHaem, 2020
MLL‐rearranged acute lymphoblastic leukemia (ALL) represents a highly aggressive ALL subtype, characterized by aberrant DNA methylation patterns. DNA methyltransferase inhibitors, such as decitabine have previously been demonstrated to be effective in ...
Pauline Schneider   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy